1. **Investigate the detailed mechanism of C18-induced mitochondrial dysfunction:**

- Explore the role of ROS and Ca2+ signaling in C18-mediated mitochondrial dysfunction.
- Determine the specific mitochondrial targets of C18 and elucidate the molecular mechanisms of its interaction with these targets.
- Investigate the impact of C18 on mitochondrial bioenergetics, including ATP production, oxygen consumption, and reactive oxygen species generation.


2. **Evaluate the in vivo efficacy of C18 against Candida albicans infections in different animal models:**

- Assess the therapeutic potential of C18 in murine models of disseminated candidiasis, oral candidiasis, and vaginal candidiasis.
- Determine the pharmacokinetic and pharmacodynamic properties of C18 in vivo, including its distribution, metabolism, and clearance.
- Investigate the potential toxicity of C18 in vivo, including its effects on host tissues and organs.


3. **Explore the potential of C18 as a broad-spectrum antifungal agent:**

- Test the antifungal activity of C18 against a wider range of Candida species, including emerging multidrug-resistant strains.
- Evaluate the efficacy of C18 against other fungal pathogens, such as Aspergillus fumigatus, Cryptococcus neoformans, and Pneumocystis jirovecii.
- Investigate the potential of C18 as a профилакти agent against fungal infections in immunocompromised patients.


4. **Investigate the potential synergistic effects of C18 with other antifungal agents:**

- Evaluate the in vitro and in vivo efficacy of C18 in combination with conventional antifungal drugs, such as fluconazole, itraconazole, and amphotericin B.
- Determine the mechanisms of synergy between C18 and other antifungal agents, including potential targets and pathways.
- Explore the potential of C18-based combination therapies to overcome antifungal resistance and improve treatment outcomes.


5. **Develop C18-based nanoformulations to enhance its antifungal activity and reduce toxicity:**

- Design and synthesize C18-loaded nanoparticles, liposomes, or micelles to improve its solubility, stability, and bioavailability.
- Evaluate the antifungal efficacy and toxicity of C18-based nanoformulations in vitro and in vivo.
- Investigate the mechanisms by which C18-based nanoformulations enhance antifungal activity and reduce toxicity.